| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Mpm Oncology Impact Management GP LLC is a 10% Owner at Viracta Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $9.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2017 | VIRX Viracta Therapeutics, Inc. | 10% Owner | Buy | 81,500 | $2.77 | $226,001.00 | +0.8% |